Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
InChi: InChI=1S/C25H22ClN5O2S/c1-13-14(2)34-25-22(13)23(16-4-6-17(26)7-5-16)28-20(24-30-29-15(3)31(24)25)12-21(33)27-18-8-10-19(32)11-9-18/h4-11
PubMed PMID: 27231153
PER977 is a water-soluble
InChi: InChI=1S/C16H14ClFN6O3/c17-10-5-13(18)16(20-7-10)27-12-3-1-9(2-4-12)15-21-23-24(22-15)8-11(19)6-14(25)26/h1-5
and 30 mg/kg
TAS-102 - CAS# 733030-01-8 Catalog No.:M6637-10S InChi: InChI=1S/C25H22ClN5O2S/c1-13-14(2)34-25-22(13)23(16-4-6-17(26)7-5-16)28-20(24-30-29-15(3)31(24)25)12-21(33)27-18-8-10-19(32)11-9-18/h4-11TAS 102, CAS No. 733030 01 8, is an investigational drug candidate for metastatic colorectal cancer. It contains trifluridine (TFT) and Tipiracil hydrochloride (TTP) in a molar ratio of 1; 0. 5. Trifluridine is a nucleoside analog, and tipiracil hydrochloride is a thymidine phosphorylase inhibitor, which prevents rapid metabolism of trifluiridine, increasing the bioavailability of trifluiridine. After oral administration of TAS 102, TFT is
US$ 65.00
US$ 101.25
US$ 110.25
US$ 114.95
US$ 129.95
US$ 108.00
US$ 139.95
US$ 144.95
US$ 16.00
US$ 200.00
US$ 115.50
US$ 109.95
US$ 186.50
US$ 122.95